Eyewear Tariffs Face Industry Pushback - Takeaways - MDSpire
Commentary & Perspectives

Eyewear Tariffs Face Industry Pushback

Vision Council urges US Trade Representative to exclude eyewear from new Section 301 tariffs

  • May 13, 2026

  • 2 min

Share

  • 1

    - The Vision Council urged USTR to exclude eyewear from tariffs. - Eyewear is classified as a necessary medical product. - Over 70% of Americans rely on prescription eyewear. - Higher tariffs could increase costs for US manufacturers. - Additional duties may limit patient access to eyewear, risking public health. - The FDA classifies prescription eyewear as a Class I medical device. - Ongoing tariffs could harm the competitiveness of US optical businesses.

Original Source(s)

Eyewear Tariffs Face Industry Pushback

  • May 13, 2026

Related Content

“Control the Contrast” Debuts Globally

SightGlass Vision launches a global campaign to educate clinicians on contrast management for slowing myopia progression

  • May 13, 2026

  • 2 min
Rethinking the Slit Lamp

Ultra-low-cost AI slit lamp brings quantitative screening closer to the community

  • May 13, 2026

  • 3 min
Astigmatism Up After COVID Restrictions

Researchers identified delayed corneal changes in schoolchildren that emerged after myopia rates had already increased during the pandemic.